60 Participants NeededMy employer runs this trial

Double-Injection Costoclavicular Block for Brachial Plexus Blocks

JA
Overseen ByJulián Aliste, M.D.
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

In 2020, a trial demonstrated that a 2-injection technique constitutes the optimal method for the costoclavicular block.

This study aims to determine the minimum amount of medication required to achieve a successful double-injection costoclavicular nerve.

Block dose assignment will be done using an up-and-down sequential method, called the Biased Coin Design (BCD).

The double-injection technique for US-guided costoclavicular block consists in depositing two thirds of the LA volume in the deep compartment (to anesthetize the posterior and medial cords), and one third of the injectate in the superficial compartment (to anesthetize the lateral cord).

The ED90 will be calculated using isotonic regression with a 95% confidence interval derived by bootstrapping.

Are You a Good Fit for This Trial?

This trial is for adults aged 18-70 with a BMI between 20 and 30, who are generally healthy or have mild to moderate health issues (ASA class 1-3).

Inclusion Criteria

Body mass index between 20 and 30
American Society of Anesthesiologists classification 1-3
I am between 18 and 70 years old.

Exclusion Criteria

I have been diagnosed with kidney failure based on my medical history or blood tests.
Allergy to local anesthetics
Pregnancy
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • Ultrasound-guided double-injection costoclavicular nerve block

Trial Overview

Researchers are comparing two different amounts of numbing medicine used in an ultrasound-guided double-injection nerve block near the collarbone. The goal is to find the lowest effective dose needed for successful anesthesia.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Costoclavicular block with lower volumeExperimental Treatment1 Intervention
Group II: Costoclavicular block with same previous successful volumeActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

Trials
476
Recruited
170,000+